Economic impact of preoperative curettage before Mohs micrographic surgery for basal cell carcinoma

Dermatologic Surgery

Volumn 32, Issue 7, 2006, Pages 916-923

  Lee, David A ^a   Ratner, Désirée ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; CURETTAGE; ECONOMIC ASPECT; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; INSURANCE; MOHS MICROGRAPHIC SURGERY; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REIMBURSEMENT; SURGEON; SURGICAL TECHNIQUE; CANCER STAGING; CANCER SURGERY; CONFOCAL MICROSCOPY; DECISION MAKING; ESTHETICS; INFORMED CONSENT; MERKEL CELL TUMOR; MORPHEA; NOTE; OPERATION DURATION; POSTOPERATIVE COMPLICATION; SCAR FORMATION; SOFT TISSUE INJURY; SQUAMOUS CELL CARCINOMA; TISSUE PRESERVATION; TUMOR VOLUME;

EID: 33745831967     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2006.32196.x     Document Type: Article

References (17)

1. Drake LA, Dinehart SM, Goltz RW, et al. Guidelines of care for Mohs micrographic surgery. American Academy of Dermatology. J Am Acad Dermatol 1995;33:271-8.
2. Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15:424-31.
3. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315-28.
4. Suhge d'Aubermont PC, Bennett RG. Failure of curettage and electrodesiccation for removal of basal cell carcinoma. Arch Dermatol 1984;120:1456-60.
5. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999;135:1177-83.
6. Mohs FE, Zitelli JA. Microscopically controlled surgery in the treatment of carcinoma of the scalp. Arch Dermatol 1981;117:764-9.
7. Menn H, Robins P, Kopf AW, Bart RS. The recurrent basal cell epithelioma: a study of 100 cases of recurrent, re-treated basal cell epitheliomas. Arch Dermatol 1971;103:628-31.
8. Arpey CJ. Is curettage useful prior to performing Mohs or excisional surgery? When and how do you use it? Dermatol Surg 2000;26:165; discussion 165-6.
9. Lutz ME. Surgical pearl: curettage before cutaneous surgery to identify an unidentifiable biopsy site. J Am Acad Dermatol 2002;46:591-3.
10. Johnson TM, Tromovitch TA, Swanson NA. Combined curettage and excision: a treatment method for primary basal cell carcinoma. J Am Acad Dermatol 1991;24:613-7.
11. Chiller K, Passaro D, McCalmont T, Vin-Christian K. Efficacy of curettage before excision in clearing surgical margins of nonmelanoma skin cancer. Arch Dermatol 2000;136:1327-32.
12. Huang CC, Boyce S, Northington M, et al. Randomized, controlled surgical trial of preoperative tumor curettage of basal cell carcinoma in Mohs micrographic surgery. J Am Acad Dermatol 2004;51:585-91.
13. Jih MH, Friedman PM, Goldberg LH, Kimyai-Asadi A. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study. Dermatol Surg 2005;31:10-5.
14. Chung VQ, Bernardo L, Jiang SB. Presurgical curettage appropriately reduces the number of Mohs stages by better delineating the subclinical extensions of tumor margins. Dermatol Surg 2005;31:(9 Pt 1):1094-9; discussion 1100.
15. Ratner D, Bagiella E. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery. Dermatol Surg 2003;29:899-903.
16. Edens BL, Bartlow GA, Haghighi P, et al. Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma. J Am Acad Dermatol 1983;9:383-8.
17. Cook J, Zitelli JA. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 1998;39:698-703.